Pancreatic neuroendocrine tumors

Although surgical resection is generally recommended for patients with localized pancreatic neuroendocrine tumors (PNETs), the impact of resection on overall survival is unknown. The authors investigated the survival advantage of pancreatic resection using a national database.

[1]  C. Ko,et al.  Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. , 2007, Journal of the American College of Surgeons.

[2]  Douglas B. Evans,et al.  Population-Based Study of Islet Cell Carcinoma , 2007, Annals of Surgical Oncology.

[3]  C. Ko,et al.  Clinicopathologic Features and Treatment Trends of Pancreatic Neuroendocrine Tumors: Analysis of 9,821 Patients , 2007, Journal of Gastrointestinal Surgery.

[4]  C. Ko,et al.  National Failure to Operate on Early Stage Pancreatic Cancer , 2007, Annals of surgery.

[5]  V. Deshpande,et al.  Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. , 2007, Archives of surgery.

[6]  J. Izbicki,et al.  Aggressive Surgery Improves Long-term Survival in Neuroendocrine Pancreatic Tumors: An Institutional Experience , 2007, Annals of surgery.

[7]  J. Goodwin,et al.  Pancreatic cancer in the general population: Improvements in survival over the last decade , 2006, Journal of Gastrointestinal Surgery.

[8]  H. Reber,et al.  Resection of pancreatic neuroendocrine tumors: results of 70 cases. , 2006, Archives of surgery.

[9]  J. Norton.  Surgical treatment of neuroendocrine metastases , 2005 .

[10]  H. Pitt,et al.  Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival? , 2005, Annals of surgery.

[11]  G. Klöppel,et al.  The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification , 2004, Annals of the New York Academy of Sciences.

[12]  J. Norton,et al.  Aggressive surgery for metastatic liver neuroendocrine tumors. , 2003, Surgery.

[13]  J. Norton,et al.  Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. , 2003, Archives of surgery.

[14]  D. Nagorney,et al.  Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. , 2003, Journal of the American College of Surgeons.

[15]  I. Modlin,et al.  A 5‐decade analysis of 13,715 carcinoid tumors , 2003, Cancer.

[16]  Jeffrey E. Lee,et al.  Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. , 2001, Surgery.

[17]  T. Lorf,et al.  Treatment of Hepatic Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Role of Liver Transplantation , 2001, World Journal of Surgery.

[18]  D. Canes,et al.  Hepatic neuroendocrine metastases: does intervention alter outcomes? , 2000, Journal of the American College of Surgeons.

[19]  A. Gardini,et al.  Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. , 2000, Hepato-gastroenterology.

[20]  H. Pitt,et al.  Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients , 1998, Journal of Gastrointestinal Surgery.

[21]  J. Norton,et al.  Surgery in Zollinger‐Ellison Syndrome Alters the Natural History of Gastrinoma , 1994, Annals of surgery.

[22]  R. Prinz,et al.  Clinical aspects of glucagon-producing islet cell tumors. , 1981, The American journal of gastroenterology.

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  R. Prinz,et al.  Endocrine Tumors of the Pancreas: Clinical Picture, Diagnosis, and Therapy , 2007 .

[25]  E. Dixon,et al.  Functioning and nonfunctioning neuroendocrine tumors of the pancreas. , 2007, Current opinion in oncology.

[26]  J. Norton.  Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases. , 2005, Best practice & research. Clinical gastroenterology.

[27]  Heinz Höfler,et al.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut , 2004, Virchows Archiv.

[28]  B. Stenkvist,et al.  Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material , 2004, Virchows Archiv A.

[29]  F. Que,et al.  Hepatic surgery for metastases from neuroendocrine tumors. , 2003, Surgical oncology clinics of North America.

[30]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[31]  B. Hirschowitz.  Surgery to cure the Zollinger-Ellison syndrome. , 1999, The New England journal of medicine.

[32]  K. Batts,et al.  Hepatic resection for metastatic neuroendocrine carcinomas. , 1995, American journal of surgery.

[33]  H. Höfler,et al.  Revised classification of neuroendocrine tumors of the lung, pancreas and gut. , 1994, Digestion.